Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats

Pain

Volumn 154, Issue 4, 2013, Pages 576-585

  Rea, Kieran ^a   Olango, Weredeselam M ^a   Harhen, Brendan ^a   Kerr, Daniel M ^a   Galligan, Rachel ^a   Fitzgerald, Sean ^a   Moore, Maeve ^a   Roche, Michelle ^a   Finn, David P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

AM251; Amygdala; Bicuculline; MPEP; Pain

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE METHOBROMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; FORMALDEHYDE; METABOTROPIC RECEPTOR 5; N OLEOYLETHANOLAMINE; PALMIDROL;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BASOLATERAL AMYGDALA; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; FEAR CONDITIONED ANALGESIA; FOOTSHOCK; GABAERGIC TRANSMISSION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84875429105     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2012.12.021     Document Type: Article

References (87)

1. O.B. Ansah, L. Goncalves, A. Almeida, and A. Pertovaara Enhanced pronociception by amygdaloid group I metabotropic glutamate receptors in nerve-injured animals Exp Neurol 216 2009 66 74
2. D. Baptista, K. Bussadori, R.L. Nunes-de-Souza, and A. Canto-de-Souza Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: influence of prior test experience Brain Res 1294 2009 29 37
3. T. Bisogno, S. Maurelli, D. Melck, L. De Petrocellis, and V. Di Marzo Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes J Biol Chem 272 1997 3315 3323
4. M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, M. Rinaldi-Carmona, G. Le Fur, and P. Casellas Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem J 312 1995 637 641
5. R.K. Butler, and D.P. Finn Stress-induced analgesia Prog Neurobiol 88 2009 184 202
6. R.K. Butler, G.K. Ford, M. Hogan, M. Roche, K.M. Doyle, J.P. Kelly, D.A. Kendall, V. Chapman, and D.P. Finn Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase J Psychopharmacol 26 2011 83 91
7. R.K. Butler, K. Rea, Y. Lang, A.M. Gavin, and D.P. Finn Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates PAIN® 140 2008 491 500
8. D.J. Calcagnetti, F.J. Helmstetter, and M.S. Fanselow Quaternary naltrexone reveals the central mediation of conditional opioid analgesia Pharmacol Biochem Behav 27 1987 529 531
9. Y. Carrasquillo, and R.W. Gereau 4th Hemispheric lateralization of a molecular signal for pain modulation in the amygdala Mol Pain 4 2008 24
10. K. Connell, N. Bolton, D. Olsen, D. Piomelli, and A.G. Hohmann Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia Neurosci Lett 397 2006 180 184
11. B. Costa, F. Comelli, I. Bettoni, M. Colleoni, and G. Giagnoni The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPAR gamma receptors and neurotrophic factors PAIN® 139 2008 541 550
12. L. Cristino, L. de Petrocellis, G. Pryce, D. Baker, V. Guglielmotti, and V. Di Marzo Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain Neuroscience 139 2006 1405 1415
13. M. Davis, and P.J. Whalen The amygdala: vigilance and emotion Mol Psychiatry 6 2001 13 34
14. L. De Petrocellis, T. Bisogno, M. Maccarrone, J.B. Davis, A. Finazzi-Agro, and V. Di Marzo The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism J Biol Chem 276 2001 12856 12863
15. M.S. Fanselow, D.J. Calcagnetti, and F.J. Helmstetter Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide J Pharmacol Exp Ther 250 1989 825 830
16. D.P. Finn, S.R. Beckett, D. Richardson, D.A. Kendall, C.A. Marsden, and V. Chapman Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors Eur J Neurosci 20 2004 848 852
17. D.P. Finn, M.D. Jhaveri, S.R. Beckett, A. Madjd, D.A. Kendall, C.A. Marsden, and V. Chapman Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats Neuroscience 138 2006 1309 1317
18. D.P. Finn Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance Immunobiology 215 2010 629 646
19. C. Flores-Gracia, A. Nuche-Bricaire, M. Crespo-Ramirez, R. Miledi, K. Fuxe, and M. Perez de la Mora GABA(A) rho receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety Psychopharmacology 212 2010 475 484
20. G.K. Ford, and D.P. Finn Clinical correlates of stress-induced analgesia: evidence from pharmacological studies PAIN® 140 2008 3 7
21. G.K. Ford, S. Kieran, K. Dolan, B. Harhen, and D.P. Finn A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats PAIN® 152 2011 2495 2504
22. H.E. Gibson, J.G. Edwards, R.S. Page, M.J. Van Hook, and J.A. Kauer TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons Neuron 57 2008 746 759
23. A.J. Good, and R.F. Westbrook Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats Behav Neurosci 109 1995 631 641
24. L.C. Gregg, K.M. Jung, J.M. Spradley, R. Nyilas, R.L. Suplita II, A. Zimmer, M. Watanabe, K. Mackie, I. Katona, D. Piomelli, and A.G. Hohmann Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-alpha initiates 2-arachidonoylglycerol formation and endocannabinoid- mediated analgesia J Neurosci 32 2012 9457 9468
25. J.A. Harris, and R.F. Westbrook Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats Behav Neurosci 109 1995 295 304
26. J.A. Harris, R.F. Westbrook, T.Q. Duffield, and M. Bentivoglio Fos expression in the spinal cord is suppressed in rats displaying conditioned hypoalgesia Behav Neurosci 109 1995 320 328
27. F.J. Helmstetter Stress-induced hypoalgesia and defensive freezing are attenuated by application of diazepam to the amygdala Pharmacol Biochem Behav 44 1993 433 438
28. F.J. Helmstetter, and P.S. Bellgowan Lesions of the amygdala block conditional hypoalgesia on the tail flick test Brain Res 612 1993 253 257
29. F.J. Helmstetter, and P.S. Bellgowan Effects of muscimol applied to the basolateral amygdala on acquisition and expression of contextual fear conditioning in rats Behav Neurosci 108 1994 1005 1009
30. F.J. Helmstetter, and J. Landeira-Fernandez Conditional hypoalgesia is attenuated by naltrexone applied to the periaqueductal gray Brain Res 537 1990 88 92
31. 2+ signaling and NFAT activation FASEB J 23 2009 183 193
32. C.M. Henstridge, N.A. Balenga, R. Schroder, J.K. Kargl, W. Platzer, L. Martini, S. Arthur, J. Penman, J.L. Whistler, E. Kostenis, M. Waldhoer, and A.J. Irving GPR55 ligands promote receptor coupling to multiple signalling pathways Br J Pharmacol 160 2010 604 614
33. M. Herkenham Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections NIDA Res Monogr 112 1991 129 145
34. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 1991 563 583
35. C.J. Hillard, S. Manna, M.J. Greenberg, R. DiCamelli, R.A. Ross, L.A. Stevenson, V. Murphy, R.G. Pertwee, and W.B. Campbell Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1) J Pharmacol Exp Ther 289 1999 1427 1433
36. A.G. Hohmann, R.L. Suplita, N.M. Bolton, M.H. Neely, D. Fegley, R. Mangieri, J.F. Krey, J.M. Walker, P.V. Holmes, J.D. Crystal, A. Duranti, A. Tontini, M. Mor, G. Tarzia, and D. Piomelli An endocannabinoid mechanism for stress-induced analgesia Nature 435 2005 1108 1112
37. A.C. Howlett The cannabinoid receptors Prostaglandins Other Lipid Mediat 68-9 2002 619 631
38. A.C. Howlett, J.M. Qualy, and L.L. Khachatrian Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs Mol Pharmacol 29 1986 307 313
39. G.W. Hubert, M. Paquet, and Y. Smith Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey substantia nigra J Neurosci 21 2001 1838 1847
40. T.U. Jarbe, M.E. Andrzejewski, and N.V. DiPatrizio Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited Pharmacol Biochem Behav 73 2002 911 919
41. M.D. Jhaveri, D. Richardson, and V. Chapman Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain Br J Pharmacol 152 2007 624 632
42. G. Ji, and V. Neugebauer Hemispheric lateralization of pain processing by amygdala neurons J Neurophysiol 102 2009 2253 2264
43. K.O. Jonsson, S. Vandevoorde, D.M. Lambert, G. Tiger, and C.J. Fowler Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide Br J Pharmacol 133 2001 1263 1275
44. K.M. Jung, R. Mangieri, C. Stapleton, J. Kim, D. Fegley, M. Wallace, K. Mackie, and D. Piomelli Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors Mol Pharmacol 68 2005 1196 1202
45. I. Katona, E.A. Rancz, L. Acsady, C. Ledent, K. Mackie, N. Hajos, and T.F. Freund Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission J Neurosci 21 2001 9506 9518
46. B.J. Kolber, M.C. Montana, Y. Carrasquillo, J. Xu, S.F. Heinemann, L.J. Muglia, and R.W. Gereau IV Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior J Neurosci 30 2010 8203 8213
47. D.M. Lambert, F.G. DiPaolo, P. Sonveaux, M. Kanyonyo, S.J. Govaerts, E. Hermans, J. Bueb, N.M. Delzenne, and E.J. Tschirhart Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors Biochim Biophys Acta 1440 1999 266 274
48. J.E. Lauckner, J.B. Jensen, H.Y. Chen, H.C. Lu, B. Hille, and K. Mackie GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current Proc Natl Acad Sci USA 105 2008 2699 2704
49. J. Lo Verme, J. Fu, G. Astarita, G. La Rana, R. Russo, A. Calignano, and D. Piomelli The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide Mol Pharmacol 67 2005 9 15
50. X.R. Lu, W.Y. Ong, and K. Mackie A light and electron microscopic study of the CB1 cannabinoid receptor in monkey basal forebrain J Neurocytol 28 1999 1045 1051
51. S. Maione, T. Bisogno, V. de Novellis, E. Palazzo, L. Cristino, M. Valenti, S. Petrosino, V. Guglielmotti, F. Rossi, and V. Di Marzo Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors J Pharmacol Exp Ther 316 2006 969 982
52. G. Marsicano, and B. Lutz Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain Eur J Neurosci 11 1999 4213 4225
53. R.C. Martinez, A.R. de Oliveira, and M.L. Brandao Conditioned and unconditioned fear organized in the periaqueductal gray are differentially sensitive to injections of muscimol into amygdaloid nuclei Neurobiol Learn Mem 85 2006 58 65
54. S. Maurelli, T. Bisogno, L. De Petrocellis, A. Di Luccia, G. Marino, and V. Di Marzo Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase' FEBS Lett 377 1995 82 86
55. E. Mezey, Z.E. Toth, D.N. Cortright, M.K. Arzubi, J.E. Krause, R. Elde, A. Guo, P.M. Blumberg, and A. Szallasi Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human Proc Natl Acad Sci USA 97 2000 3655 3660
56. V. Micale, L. Cristino, A. Tamburella, S. Petrosino, G.M. Leggio, F. Drago, and V. Di Marzo Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels Neuropsychopharmacology 34 2009 593 606
57. J. Muller, K.P. Corodimas, Z. Fridel, and J.E. LeDoux Functional inactivation of the lateral and basal nuclei of the amygdala by muscimol infusion prevents fear conditioning to an explicit conditioned stimulus and to contextual stimuli Behav Neurosci 111 1997 683 691
58. R.L. Nunes-de-Souza, A. Canto-de-Souza, M. Da-Costa, R.V. Fornari, F.G. Graeff, and I.R. Pela Anxiety-induced antinociception in mice. Effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam Psychopharmacology (Berl) 150 2000 300 310
59. R. Nyilas, B. Dudok, G.M. Urbán, K. Mackie, M. Watanabe, B.F. Cravatt, T.F. Freund, and I. Katona Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals J Neurosci 28 2008 1058 1063
60. W.M. Olango, M. Roche, G.K. Ford, B. Harhen, and D.P. Finn The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nocicpetive tone Br J Pharmacol 165 2012 2549 2560
61. W.Y. Ong, and K. Mackie A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain Neuroscience 92 1999 1177 1191
62. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1997 Academic Press San Diego, CA
63. M. Perez de la Mora, D. Lara-Garcia, K.X. Jacobsen, M. Vazquez-Garcia, M. Crespo-Ramirez, C. Flores-Gracia, E. Escamilla-Marvan, and K. Fuxe Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety Eur J Neurosci 23 2006 2749 2759
64. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, M.R. Elphick, P.J. Greasley, H.S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, and R.A. Ross International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 Pharmacol Rev 62 2010 588 631
65. K. Rea, and D.P. Finn The role of supraspinal GABA and glutamate in the mediation and modulation of pain S. D'Alonso, K.L. Grasso, Acute pain: causes, effects and treatment 2009 Nova Science Publishers Hauppauge, NY 169 212
66. K. Rea, Y. Lang, and D.P. Finn Alterations in extracellular levels of gamma-aminobutyric acid in the rat basolateral amygdala and periaqueductal gray during conditioned fear, persistent pain and fear-conditioned analgesia J Pain 10 2009 1088 1098
67. K. Rea, M. Roche, and D.P. Finn Modulation of conditioned fear, fear-conditioned analgesia, and brain regional c-Fos expression following administration of muscimol into the rat basolateral amygdala J Pain 12 2011 712 721
68. M. Roche, P. Johnston, O.N. Mhuircheartaigh, W.M. Olango, K. Mackie, and D.P. Finn Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear Eur J Pain 14 2010 487 495
69. M. Roche, E. O'Connor, C. Diskin, and D.P. Finn The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats Eur J Neurosci 26 2007 2643 2653
70. S.M. Rodrigues, E.P. Bauer, C.R. Farb, G.E. Schafe, and J.E. LeDoux The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala J Neurosci 22 2002 5219 5229
71. J.W. Rudy, and P. Matus-Amat DHPG activation of group 1 mGluRs in BLA enhances fear conditioning Learn Mem 16 2009 421 425
72. E. Ryberg, N. Larsson, S. Sjogren, S. Hjorth, N.O. Hermansson, J. Leonova, T. Elebring, K. Nilsson, T. Drmota, and P.J. Greasley The orphan receptor GPR55 is a novel cannabinoid receptor Br J Pharmacol 152 2007 1092 1101
73. H. Sharir, and M.E. Abood Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacol Ther 126 2010 301 313
74. T. Sheskin, L. Hanus, J. Slager, Z. Vogel, and R. Mechoulam Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor J Med Chem 40 1997 659 667
75. R.M. Shin, K. Tully, Y. Li, J.H. Cho, M. Higuchi, T. Suhara, and V.Y. Bolshakov Hierarchical order of coexisting pre- and postsynaptic forms of long-term potentiation at synapses in amygdala Proc Natl Acad Sci USA 107 2010 19073 19078
76. R.P. Soltis, J.C. Cook, A.E. Gregg, and B.J. Sanders Interaction of GABA and excitatory amino acids in the basolateral amygdala: role in cardiovascular regulation J Neurosci 17 1997 9367 9374
77. O. Stork, F.Y. Ji, and K. Obata Reduction of extracellular GABA in the mouse amygdala during and following confrontation with a conditioned fear stimulus Neurosci Lett 327 2002 138 142
78. N.M. Strangman, S.L. Patrick, A.G. Hohmann, K. Tsou, and J.M. Walker Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity Brain Res 813 1998 323 328
79. M. Suardiaz, G. Estivill-Torrus, C. Goicoechea, A. Bilbao, and F. Rodriguez de Fonseca Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain PAIN® 133 2007 99 110
80. R.L. Suplita 2nd, J.N. Farthing, T. Gutierrez, and A.G. Hohmann Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla Neuropharmacology 49 2005 1201 1209
81. S.J. Tallaksen-Greene, K.W. Kaatz, C. Romano, and R.L. Albin Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons Brain Res 780 1998 210 217
82. A. Toth, J. Boczan, N. Kedei, E. Lizanecz, Z. Bagi, Z. Papp, I. Edes, L. Csiba, and P.M. Blumberg Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain Brain Res Mol Brain Res 135 2005 162 168
83. K. Tsou, K. Mackie, M.C. Sanudo-Pena, and J.M. Walker Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing gabaergic interneurons in the rat hippocampal formation Neuroscience 93 1999 969 975
84. K. Tsou, S. Brown, M.C. Sañudo-Peña, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system Neuroscience 83 1998 393 411
85. S. Walsh, A.M. Gorman, D.P. Finn, and E. Dowd The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats Brain Res 1363 2010 40 48
86. G.S. Watson, K.J. Sufka, and T.J. Coderre Optimal scoring strategies and weights for the formalin test in rats PAIN® 70 1997 53 58
87. C. Zschenderlein, C. Gebhardt, O. Von Bohlen Und Halbach, C. Kulisch, and D. Albrecht Capsaicin-induced changes in LTP in the lateral amygdala are mediated by TRPV1 PLoS One 6 2011 e16116